Click here to go to the previous page
Program Code:
REG
Time:
12:00 AM to 1:00 AM
REG005: Government Enforcement: What Every Life Sciences Company Should Know
REG010: China: Pharmaceutical Development in an Emerging Market
REG020: FDA Town Hall
REG030: FDA/EMEA Town Hall
REG040: Drug Safety and PDUFA IV: Overview of Critical Issues in Congress
REG050: Safe or Effective? FDA's, the Industry's and the Patient's Regulatory Dilemma
REG060: Biosimilars: The European Union's approach
REG070: Clinical Risk Management: Design Considerations and Good Review Management Principles